Position history for ProShare Advisors LLC's holdings in Catalyst Pharmaceuticals Inc
Current Value
$445,927
Current Shares
18,010
Total Value Change
+$180,087
Total Shares Change
+848
Decreased |
| 18,010 |
-19.9% |
| $445,927 |
| 0.0% |
| $23.92 |
0 |
| 2025-Q4 | Increased | 22,499 | +3.2% | $525,127 | 0.0% | $23.29 | 25 |
| 2025-Q3 | Decreased | 21,797 | -15.6% | $429,401 | 0.0% | $19.55 | 0 |
| 2025-Q2 | Decreased | 25,821 | -2.9% | $560,316 | 0.0% | $21.78 | 0 |
| 2025-Q1 | Decreased | 26,593 | -21.1% | $644,882 | 0.0% | $24.69 | 0 |
| 2024-Q4 | Increased | 33,699 | +44.5% | $703,297 | 0.0% | $21.07 | 33 |
| 2024-Q3 | Increased | 23,320 | +35.9% | $463,601 | 0.0% | $19.56 | 31 |
| 2024-Q2 | Decreased | 17,162 | -23.6% | $265,840 | 0.0% | $15.49 | 0 |